THE RELATIONSHIP BETWEEN STOPPER POSITION AND INJECTION VOLUME IN RANIBIZUMAB AND AFLIBERCEPT PREFILLED SYRINGES-Reference-Cited by-同舟云学术

THE RELATIONSHIP BETWEEN STOPPER POSITION AND INJECTION VOLUME IN RANIBIZUMAB AND AFLIBERCEPT PREFILLED SYRINGES

Published:2021-12 Issue:12 Volume:41 Page:2510-2514
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Hinkle John W.,Hsu Jason

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference11 articles.

1. The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab;Storey;Am J Ophthalmol,2019

2. Prefilled syringes for intravitreal drug delivery;Sassalos;Clin Ophthalmol,2019

3. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point;Brown;Ophthalmology,2013

4. High-dose high-frequency aflibercept for recalcitrant neovascular age-related macular degeneration;You;Retina,2018

5. Pre-filled aflibercept syringes—variability in expressed fluid volumes and a case series of transient central retinal artery occlusions;Gallagher;Eye,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation;Frontiers in Medicine;2023-10-25

2. SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS;Retina;2023-03

3. Deformation of Aflibercept and Ranibizumab Syringes Causes Variation in Intravitreal Injection Volume and Risks Retinal Tear Formation;Ophthalmology Science;2022-12

4. Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes;Scientific Reports;2022-10-28

5. Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe;International Journal of Retina and Vitreous;2022-04-05